3. 脊髄性筋萎縮症 Spinal muscular atrophy Clinical trials / Disease details

臨床試験数 : 237 / 薬物数 : 123 - (DrugBank : 29) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 75

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03648658 (ClinicalTrials.gov)	February 18, 2019	8/8/2018	Paracetamol Study in Patients With Low Muscle Mass	Pharmacokinetics and Safety of Treatment With Paracetamolin Children and Adults With Spinal Muscular ...	SMA II;Cerebral Palsy	Drug: Paracetamol 120Mg/5mL Oral Suspension	Mette Cathrine Oerngreen	Elsass Foundation	Recruiting	6 Years	45 Years	All	48	Phase 4	Denmark
2	EUCTR2018-002295-40-DK (EUCTR)	11/09/2018	11/07/2018	Is treatment with the painkiller paracetamolsafe in patients with spinal muscular atrophy and cerebr ...	Pharmacokinetics and safety of treatment with paracetamolin children and adults with spinal muscular ...	Spinal muscular atrophy type II (SMA II)Cerebral palsy (CP);Therapeutic area: Diseases [C] - Nervous ...	INN or Proposed INN: Paracetamol Other descriptive name: PARACETAMOL	Copenhagen Neuromuscular Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	24	Phase 1;Phase 4	Denmark

First Previous1Next Last